Cladribine is a medication used to treat hairy cell leukemia (HCL, leukemic
reticuloendotheliosis) and B-cell chronic lymphocytic leukemia. Its chemical
name is ...
(KLA-drih-bean). Trade name: Leustatin<sup>TM</sup> Other names: 2-CdA, 2-
Chlorodeoxyadenosine. Cladribine is the generic name for the trade name drug
WARNING: Cladribine injection should be administered under the supervision of
a qualified physician experienced in the use of antineoplastic therapy.
Sep 11, 2015 ... Cladribine is a type of chemotherapy that belongs to a class of drugs called
antimetabolites. These medications are taken up by cells and are ...
Dec 16, 2015 ... Read about the cancer treatment drug cladribine, also called LITAK and Leustat,
including what it is, how it works and possible side effects.
Jun 15, 2016 ... Cladribine injection must be given in a hospital or medical facility under the
supervision of a doctor who is experienced in giving chemotherapy ...
Cladribine differs structurally from deoxyadenosine only by the presence of a
chlorine atom at position 2 of the purine ring, which results in resistance to ...
Find out more about cladribine (Leustat ®, LITAK ®), a chemotherapy drug used
to treat hairy cell leukaemia and B-cell chronic lymphocytic leukaemia (CLL)
Cladribine is a purine nucleoside antimetabolite analogue. Cladribine
triphosphate, a phosphorylated metabolite of cladribine, incorporates into DNA,
Oct 2, 2015 ... Cladribine is a cancer drug studied for use as a disease modifying drug in
relapsing remitting MS, but it was not approved by drug regulators.